Lilly CEO Says Europe Needs Incentives To Reward Innovators, Investors
This article was originally published in The Pink Sheet Daily
Executive Summary
Eli Lilly CEO John Lechleiter says Europe needs better pricing and access policies if the region wants to stop and reverse its decline in drug innovation.